echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > AP&T: The acute effect of metformin on portal pressure in patients with liver cirrhosis and portal hypertension

    AP&T: The acute effect of metformin on portal pressure in patients with liver cirrhosis and portal hypertension

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



     


     


    Figure: The relationship between HVPG levels and inflammation indicators


    Therefore, the author concludes that a single oral dose of metformin can rapidly reduce HVPG in patients with portal hypertension without affecting systemic or liver hemodynamics or inflammation biomarkers


     

    Original source:

    Nikolaj Rittig.


    Randomised clinical study: acute effects of metformin versus placebo on portal pressure in patients with cirrhosis and portal hypertension.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.